AnnotSV ID	SV chrom	SV start	SV end	SV length	SV type	Samples_ID	AnnotSV type	Gene name	NM	CDS length	tx length	location	intersectStart	intersectEnd	DGV_GAIN_IDs	DGV_GAIN_n_samples_with_SV	DGV_GAIN_n_samples_tested	DGV_GAIN_Frequency	DGV_LOSS_IDs	DGV_LOSS_n_samples_with_SV	DGV_LOSS_n_samples_tested	DGV_LOSS_Frequency	GD_ID	GD_AN	GD_N_HET	GD_N_HOMALT	GD_AF	GD_POPMAX_AF	GD_ID_others	DDD_SV	DDD_DUP_n_samples_with_SV	DDD_DUP_Frequency	DDD_DEL_n_samples_with_SV	DDD_DEL_Frequency	1000g_event	1000g_AF	1000g_max_AF	IMH_ID	IMH_AF	IMH_ID_others	promoters	dbVar_event	dbVar_variant	dbVar_status	TADcoordinates	ENCODEexperiments	GCcontent_left	GCcontent_right	Repeats_coord_left	Repeats_type_left	Repeats_coord_right	Repeats_type_right	ACMG	HI_CGscore	TriS_CGscore	DDD_status	DDD_mode	DDD_consequence	DDD_disease	DDD_pmids	HI_DDDpercent	synZ_ExAC	misZ_ExAC	pLI_ExAC	delZ_ExAC	dupZ_ExAC	cnvZ_ExAC	Mim Number	Phenotypes	Inheritance	morbidGenes	morbidGenesCandidates	AnnotSV rankingg
4	12_88444062_88444278_	12	88444062	88444278	216	DEL	SGT162459	full	CEP290								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV							0.255	0.345													13.34	-2.01006074934114	-1.90443165293259		0.22533823471436	0.335258212314732	0.330514096986351				yes	yes	
5	12_88444062_88444278_	12	88444062	88444278	216	DEL	SGT162459	split	CEP290	NM_025114	81.0	217.0	intron52-intron53	88444062.0	88444278.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV														30.0	0	confirmed/confirmed/confirmed/confirmed/confirmed	biallelic/biallelic/biallelic/biallelic/biallelic	loss of function/loss of function/loss of function/loss of function/loss of function	BARDET-BIEDL SYNDROME TYPE 14/SENIOR-LOKEN SYNDROME TYPE 6/LEBER CONGENITAL AMAUROSIS TYPE 10/JOUBERT SYNDROME TYPE 5/MECKEL SYNDROME TYPE 4	/16682973/17554762;16909394/17564967;16682970;16682973/17564974;17705300	13.34	-2.01006074934114	-1.90443165293259	1.70540211110052e-31	0.22533823471436	0.335258212314732	0.330514096986351	610142	Leber congenital amaurosis 10, 611755 (3)/ Joubert syndrome 5, 610188 (3)/ Senior-Loken syndrome 6, 610189 (3)/ ?Bardet-Biedl syndrome 14, 615991 (3)/ Meckel syndrome 4, 611134 (3)	/AR/AR/AR/AR	yes	yes	
6	12_88449303_88449543_	12	88449303	88449543	240	DEL	SGT162459	full	CEP290								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV							0.34	0.245	12:88448588-88449250	L2a											13.34	-2.01006074934114	-1.90443165293259		0.22533823471436	0.335258212314732	0.330514096986351				yes	yes	
7	12_88449303_88449543_	12	88449303	88449543	240	DEL	SGT162459	split	CEP290	NM_025114	143.0	241.0	intron49-intron50	88449303.0	88449543.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV														30.0	0	confirmed/confirmed/confirmed/confirmed/confirmed	biallelic/biallelic/biallelic/biallelic/biallelic	loss of function/loss of function/loss of function/loss of function/loss of function	BARDET-BIEDL SYNDROME TYPE 14/SENIOR-LOKEN SYNDROME TYPE 6/LEBER CONGENITAL AMAUROSIS TYPE 10/JOUBERT SYNDROME TYPE 5/MECKEL SYNDROME TYPE 4	/16682973/17554762;16909394/17564967;16682970;16682973/17564974;17705300	13.34	-2.01006074934114	-1.90443165293259	1.70540211110052e-31	0.22533823471436	0.335258212314732	0.330514096986351	610142	Leber congenital amaurosis 10, 611755 (3)/ Joubert syndrome 5, 610188 (3)/ Senior-Loken syndrome 6, 610189 (3)/ ?Bardet-Biedl syndrome 14, 615991 (3)/ Meckel syndrome 4, 611134 (3)	/AR/AR/AR/AR	yes	yes	
8	12_88481536_88482887_	12	88481536	88482887	1351	DEL	SGT162459	full	CEP290								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_DEL_12_153026;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV							0.325	0.3	12:88481228-88481520/12:88481527-88481555	AluY/AT_rich	12:88482488-88482790	AluJr									13.34	-2.01006074934114	-1.90443165293259		0.22533823471436	0.335258212314732	0.330514096986351				yes	yes	
9	12_88481536_88482887_	12	88481536	88482887	1351	DEL	SGT162459	split	CEP290	NM_025114	246.0	1352.0	exon31-intron32	88481536.0	88482887.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_12_153023;gnomAD_v2_DEL_12_153026;gnomAD_v2_INV_12_568;gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:88441736-88714358_DUP;12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:68157543-91072771_INV;12:70180800-110320036_INV														30.0	0	confirmed/confirmed/confirmed/confirmed/confirmed	biallelic/biallelic/biallelic/biallelic/biallelic	loss of function/loss of function/loss of function/loss of function/loss of function	BARDET-BIEDL SYNDROME TYPE 14/SENIOR-LOKEN SYNDROME TYPE 6/LEBER CONGENITAL AMAUROSIS TYPE 10/JOUBERT SYNDROME TYPE 5/MECKEL SYNDROME TYPE 4	/16682973/17554762;16909394/17564967;16682970;16682973/17564974;17705300	13.34	-2.01006074934114	-1.90443165293259	1.70540211110052e-31	0.22533823471436	0.335258212314732	0.330514096986351	610142	Leber congenital amaurosis 10, 611755 (3)/ Joubert syndrome 5, 610188 (3)/ Senior-Loken syndrome 6, 610189 (3)/ ?Bardet-Biedl syndrome 14, 615991 (3)/ Meckel syndrome 4, 611134 (3)	/AR/AR/AR/AR	yes	yes	
15	12_94729282_94729522_	12	94729282	94729522	240	DEL	SGT162459	full	CEP83								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:70180800-110320036_INV							0.24	0.32													24.79										yes		
16	12_94729282_94729522_	12	94729282	94729522	240	DEL	SGT162459	split	CEP83	NM_001346457	77.0	241.0	intron10-intron11	94729282.0	94729522.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:70180800-110320036_INV																confirmed	biallelic	loss of function	INFANTILE NEPHRONOPHTHISIS AND INTELLECTUAL DISABILITY	24882706	24.79							615847	Nephronophthisis 18, 615862 (3)	AR	yes		
17	12_94805391_94805703_	12	94805391	94805703	312	DEL	SGT162459	full	CEP83								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:70180800-110320036_INV							0.315	0.285													24.79										yes		
18	12_94805391_94805703_	12	94805391	94805703	312	DEL	SGT162459	split	CEP83	NM_001346457	152.0	313.0	intron2-intron3	94805391.0	94805703.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_INV_12_581			-1.0		-1.0		-1.0	-1.0		-1	12:11501487-96031049_INV;12:40933233-113477160_INV;12:52732131-95819428_INV;12:70180800-110320036_INV																confirmed	biallelic	loss of function	INFANTILE NEPHRONOPHTHISIS AND INTELLECTUAL DISABILITY	24882706	24.79							615847	Nephronophthisis 18, 615862 (3)	AR	yes		
19	14_89310063_89310279_	14	89310063	89310279	216	DEL	SGT162459	full	TTC8								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DUP_14_39646;gnomAD_v2_INV_14_644	14:89309910-89310392	1.0	0.001183432	0.0	0.0		-1.0	-1.0		-1								0.285	0.265													23.34	1.43813383450859	-0.287433681641527	0.871693438184299	0.400424639684612	-0.872350890054914	-0.491011121041774				yes	yes	
20	14_89310063_89310279_	14	89310063	89310279	216	DEL	SGT162459	split	TTC8	NM_001288781	46.0	217.0	intron6-intron7	89310063.0	89310279.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DUP_14_39646;gnomAD_v2_INV_14_644	14:89309910-89310392	1.0	0.001183432	0.0	0.0		-1.0	-1.0		-1															30.0	Not yet evaluated	confirmed/confirmed	biallelic/biallelic	uncertain/loss of function	RETINITIS PIGMENTOSA TYPE 51/BARDET-BIEDL SYNDROME TYPE 8	20451172/	23.34	1.43813383450859	-0.287433681641527	0.871693438184299	0.400424639684612	-0.872350890054914	-0.491011121041774	608132	Bardet-Biedl syndrome 8, 615985 (3)/ ?Retinitis pigmentosa 51, 613464 (3)	AR	yes	yes	
24	15_72987193_72987342_	15	72987193	72987342	149	DEL	SGT162459	full	BBS4								0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	15:41853703-76553742_INV;15:41859872-76553211_INV;15:41860713-76553027_INV;15:41861791-76552734_INV;15:41862486-76552776_INV;15:41864024-76552620_INV							0.31	0.23	15:72987091-72987211	L4											25.16	-1.73328803803995	-2.4726949727852	0.0018066160119506							yes		
25	15_72987193_72987342_	15	72987193	72987342	149	DEL	SGT162459	split	BBS4	NM_001252678	0.0	150.0	intron1-intron1	72987193.0	72987342.0		0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	15:41853703-76553742_INV;15:41859872-76553211_INV;15:41860713-76553027_INV;15:41861791-76552734_INV;15:41862486-76552776_INV;15:41864024-76552620_INV																confirmed	biallelic	loss of function	BARDET-BIEDL SYNDROME TYPE 4		25.16	-1.73328803803995	-2.4726949727852	0.0018066160119506				600374	Bardet-Biedl syndrome 4, 615982 (3)	AR	yes		
26	16_53692604_53692868_	16	53692604	53692868	264	DEL	SGT162459	full	RPGRIP1L								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_16_181531			-1.0		-1.0		-1.0	-1.0		-1	16:24121263-80276578_INV;16:29238284-88227116_INV;16:30150443-68035917_INV;16:51223532-58015294_INV							0.3	0.36													9.18	0.0419261651834991	-1.15375168844272		-0.0420247704968656	0.032150923943796	0.0518905130104479				yes	yes	
27	16_53692604_53692868_	16	53692604	53692868	264	DEL	SGT162459	split	RPGRIP1L	NM_015272	108.0	265.0	intron10-intron11	53692604.0	53692868.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DEL_16_181531			-1.0		-1.0		-1.0	-1.0		-1	16:24121263-80276578_INV;16:29238284-88227116_INV;16:30150443-68035917_INV;16:51223532-58015294_INV																confirmed/confirmed/confirmed	biallelic/biallelic/biallelic	loss of function/loss of function/loss of function	COACH SYNDROME/MECKEL SYNDROME TYPE 5/JOUBERT SYNDROME TYPE 7	/17558409/18565097;17558409;17558407	9.18	0.0419261651834991	-1.15375168844272	2.96472816568096e-14	-0.0420247704968656	0.032150923943796	0.0518905130104479	610937	Joubert syndrome 7, 611560 (3)/ Meckel syndrome 5, 611561 (3)/ ?COACH syndrome 3, 619113 (3)	AR/AR/	yes	yes	
28	16_56518218_56518367_	16	56518218	56518367	149	DEL	SGT162459	full	BBS2								0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	16:24121263-80276578_INV;16:29238284-88227116_INV;16:30150443-68035917_INV;16:51223532-58015294_INV							0.42	0.25	16:56517918-56518215	AluSc8											15.38	0.85135416844936	0.807273389528143		-0.427104130585604	1.11941610564312	0.52797039338751				yes		
29	16_56518218_56518367_	16	56518218	56518367	149	DEL	SGT162459	split	BBS2	NM_031885	0.0	112.0	exon17-txEnd	56518256.0	56518367.0		0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	16:24121263-80276578_INV;16:29238284-88227116_INV;16:30150443-68035917_INV;16:51223532-58015294_INV																confirmed	biallelic	loss of function	BARDET-BIEDL SYNDROME TYPE 2		15.38	0.85135416844936	0.807273389528143	2.6187601899811004e-10	-0.427104130585604	1.11941610564312	0.52797039338751	606151	Retinitis pigmentosa 74, 616562 (3)/ Bardet-Biedl syndrome 2, 615981 (3)	AR	yes		
41	2_170363030_170363270_	2	170363030	170363270	240	DEL	SGT162459	full	BBS5								0	0	-1.0	gssvL67574	2	11287	0.0001772					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	2:170300960-170365208_DUP;2:37574354-210299893_INV;2:104416902-188067495_INV;2:122235797-235423496_INV;2:125267534-203702062_INV;2:137647843-222431685_INV;2:143803781-206683541_INV;2:161282412-228293469_INV;2:164519753-203200073_INV							0.23	0.41	2:170362348-170362978/2:170362994-170363044	SVA_D/AT_rich	2:170363273-170363571	AluSx1									9.97	0.649602902918701	1.04538829841867	0.0399835730072617	-2.56653802186041	-0.100697400588565	-1.10466297310967				yes		
42	2_170363030_170363270_	2	170363030	170363270	240	DEL	SGT162459	split	BBS5	NM_152384	0.0	136.0	exon12-txEnd	170363030.0	170363165.0		0	0	-1.0	gssvL67574	2	11287	0.0001772					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	2:170300960-170365208_DUP;2:37574354-210299893_INV;2:104416902-188067495_INV;2:122235797-235423496_INV;2:125267534-203702062_INV;2:137647843-222431685_INV;2:143803781-206683541_INV;2:161282412-228293469_INV;2:164519753-203200073_INV														30.0	0	confirmed	biallelic	loss of function	BARDET-BIEDL SYNDROME TYPE 5		9.97	0.649602902918701	1.04538829841867	0.0399835730072617	-2.56653802186041	-0.100697400588565	-1.10466297310967	603650	Bardet-Biedl syndrome 5, 615983 (3)	AR	yes		
43	4_39188105_39196353_	4	39188105	39196353	8248	DEL	SGT162459	full	WDR19								0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	4:4773638-77530254_INV;4:21758290-84442445_INV;4:21758875-84442542_INV;4:24549534-125995071_INV;4:32219468-79170284_INV							0.4	0.445	4:39187817-39188124	AluSx1											40.57	-1.32040603637607	0.0244581518860151		0.803961953720097	1.54835355357281	1.47186466603661				yes	yes	
44	4_39188105_39196353_	4	39188105	39196353	8248	DEL	SGT162459	split	WDR19	NM_025132	311.0	8249.0	intron2-intron5	39188105.0	39196353.0		0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1	4:4773638-77530254_INV;4:21758290-84442445_INV;4:21758875-84442542_INV;4:24549534-125995071_INV;4:32219468-79170284_INV																confirmed/confirmed	biallelic/biallelic	loss of function/uncertain	CRANIOECTODERMAL DYSPLASIA 4/ASPHYXIATING THORACIC DYSTROPHY 5	22019273/19430947	40.57	-1.32040603637607	0.0244581518860151	1.51314968026696e-07	0.803961953720097	1.54835355357281	1.47186466603661	608151	Nephronophthisis 13, 614377 (3)/ Senior-Loken syndrome 8, 616307 (3)/ ?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)/ ?Cranioectodermal dysplasia 4, 614378 (3)	AR	yes	yes	
53	5_37183727_37183835_	5	37183727	37183835	108	DEL	SGT162459	full	CPLANE1							gssvG29751	4	13760	0.0002907		0	0	-1.0					-1	-1	gnomAD_v2_DUP_5_15019;gnomAD_v2_DUP_5_15021;gnomAD_v2_DUP_5_15022			-1.0		-1.0	DUP	0.00039936	0.001		-1	5:37127778-37227185_DUP;5:17480874-53788931_INV;5:24758284-101693420_INV;5:28691216-97582419_INV							0.29	0.285			5:37183889-37183966	MIR3																			yes		
54	5_37183727_37183835_	5	37183727	37183835	108	DEL	SGT162459	split	CPLANE1	NM_023073	75.0	109.0	intron25-exon26	37183727.0	37183835.0	gssvG29751	4	13760	0.0002907		0	0	-1.0					-1	-1	gnomAD_v2_DUP_5_15019;gnomAD_v2_DUP_5_15021;gnomAD_v2_DUP_5_15022			-1.0		-1.0	DUP	0.00039936	0.001		-1	5:37127778-37227185_DUP;5:17480874-53788931_INV;5:24758284-101693420_INV;5:28691216-97582419_INV																confirmed	biallelic	loss of function	JOUBERT SYNDROME									614571	Orofaciodigital syndrome VI, 277170 (3)/ Joubert syndrome 17, 614615 (3)	AR	yes		
55	5_37183727_37183835_	5	37183727	37183835	108	DEL	SGT162459	full	CPLANE1							gssvG29751	4	13760	0.0002907		0	0	-1.0					-1	-1	gnomAD_v2_DUP_5_15019;gnomAD_v2_DUP_5_15021;gnomAD_v2_DUP_5_15022			-1.0		-1.0	DUP	0.00039936	0.001		-1	5:37127778-37227185_DUP;5:17480874-53788931_INV;5:24758284-101693420_INV;5:28691216-97582419_INV							0.29	0.285			5:37183889-37183966	MIR3																			yes		
58	7_33195173_33195389_	7	33195173	33195389	216	DEL	SGT162459	full	BBS9								0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DUP_7_21062	7:32981355-33431457	0.0	0.0	1.0	0.001183432		-1.0	-1.0		-1	7:6326173-37121976_INV;7:23891012-65526751_INV;7:33013221-55782515_INV							0.295	0.3													17.13	-0.989035894351638	-1.15018109964609		-2.43637392050626	-2.53125239294469	-2.47162789907313				yes		
59	7_33195173_33195389_	7	33195173	33195389	216	DEL	SGT162459	split	BBS9	NM_001348036	66.0	217.0	intron3-intron4	33195173.0	33195389.0		0	0	-1.0		0	0	-1.0					-1	-1	gnomAD_v2_DUP_7_21062	7:32981355-33431457	0.0	0.0	1.0	0.001183432		-1.0	-1.0		-1	7:6326173-37121976_INV;7:23891012-65526751_INV;7:33013221-55782515_INV																confirmed	biallelic	loss of function	BARDET-BIEDL SYNDROME TYPE 9		17.13	-0.989035894351638	-1.15018109964609	1.03511469236621e-07	-2.43637392050626	-2.53125239294469	-2.47162789907313	607968;607968	Bardet-Biedl syndrome 9, 615986 (3);Bardet-Biedl syndrome 9, 615986 (3)	AR;AR	yes		
63	9_103046725_103046911_	9	103046725	103046911	186	DUP	SGT162459	full	INVS								0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1								0.64	0.45			9:103046933-103047121	L1MDa									32.05	-0.173499360500531	0.83534026352955		-0.0702548912336731	-0.517682474060226	-0.36805824420781				yes		
64	9_103046725_103046911_	9	103046725	103046911	186	DUP	SGT162459	split	INVS	NM_001318381	161.0	187.0	exon14-intron14	103046725.0	103046911.0		0	0	-1.0		0	0	-1.0					-1	-1				-1.0		-1.0		-1.0	-1.0		-1																						32.05	-0.173499360500531	0.83534026352955	2.13647521362233e-06	-0.0702548912336731	-0.517682474060226	-0.36805824420781	243305	Nephronophthisis 2, infantile, 602088 (3)	AR	yes		
